Oramed Pharmaceuticals (Seite 1270)
eröffnet am 28.03.07 10:26:47 von
neuester Beitrag 07.05.24 21:17:15 von
neuester Beitrag 07.05.24 21:17:15 von
Beiträge: 19.668
ID: 1.121.564
ID: 1.121.564
Aufrufe heute: 9
Gesamt: 1.542.753
Gesamt: 1.542.753
Aktive User: 0
ISIN: US68403P2039 · WKN: A1CTNU · Symbol: OJU1
2,1300
EUR
-1,34 %
-0,0290 EUR
Letzter Kurs 10:28:47 Tradegate
Neuigkeiten
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
5,0000 | +99.999,00 | |
0,9998 | +122,18 | |
17,570 | +77,92 | |
0,8970 | +75,20 | |
34,70 | +68,45 |
Wertpapier | Kurs | Perf. % |
---|---|---|
4,8500 | -14,31 | |
1,3900 | -15,76 | |
0,6460 | -19,25 | |
7,5600 | -20,75 | |
16,510 | -26,78 |
Beitrag zu dieser Diskussion schreiben
Lock-Up Agreements. We, our directors and executive officers have entered into lock-up agreements with the placement agent. Under these agreements, we
and these other individuals have agreed, subject to specified exceptions, not to sell or transfer any common stock or securities convertible into, or exchangeable
or exercisable for, our common stock, during a period ending 90 days after the date of this prospectus supplement, without first obtaining the written consent
of the placement agent. Specifically, we and these other individuals have agreed, in part, not to:
· offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of any shares of common stock,
or any options or warrants to purchase any shares of our common stock, or any securities convertible into, exchangeable for or that
represent the right to receive shares of common stock; or
· engage in any hedging or other transactions, including, without limitation, any short sale or any purchase, sale or grant of any right
(including without limitation any put or call option) with respect to any of the shares of common stock or with respect to any security that
includes, relates to, or derives any significant part of its value from the individual’s shares of common stock.
Notwithstanding these limitations, these shares of common stock may be transferred under limited circumstances, including, without limitation, by gift, will
or intestate succession.
The 90-day period is subject to extension if (1) during the last 17 days of the restricted period we issue an earnings release or material news or a material event
relating to us occurs or (2) prior to the expiration of the restricted period, we announce that we will release earnings results during the 16-day period beginning
on the last day of the restricted period, in which case the restrictions imposed in the lock-up agreements will continue to apply until the expiration of the 18-day
period beginning on the issuance of the earnings release or the occurrence of the material news or material event. In addition, if the placement agent agrees to
release any party from the restrictions set forth in the lock-up agreement with such party prior to the expiration of the restricted period, all other parties subject
to the lock-up agreement shall be entitled to a proportionate release of their shares of common stock from the lock-up agreement restrictions.
Our common stock is traded on Nasdaq under the symbol “ORMP.”
The placement agent may distribute this prospectus supplement and the accompanying prospectus electronically.
and these other individuals have agreed, subject to specified exceptions, not to sell or transfer any common stock or securities convertible into, or exchangeable
or exercisable for, our common stock, during a period ending 90 days after the date of this prospectus supplement, without first obtaining the written consent
of the placement agent. Specifically, we and these other individuals have agreed, in part, not to:
· offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of any shares of common stock,
or any options or warrants to purchase any shares of our common stock, or any securities convertible into, exchangeable for or that
represent the right to receive shares of common stock; or
· engage in any hedging or other transactions, including, without limitation, any short sale or any purchase, sale or grant of any right
(including without limitation any put or call option) with respect to any of the shares of common stock or with respect to any security that
includes, relates to, or derives any significant part of its value from the individual’s shares of common stock.
Notwithstanding these limitations, these shares of common stock may be transferred under limited circumstances, including, without limitation, by gift, will
or intestate succession.
The 90-day period is subject to extension if (1) during the last 17 days of the restricted period we issue an earnings release or material news or a material event
relating to us occurs or (2) prior to the expiration of the restricted period, we announce that we will release earnings results during the 16-day period beginning
on the last day of the restricted period, in which case the restrictions imposed in the lock-up agreements will continue to apply until the expiration of the 18-day
period beginning on the issuance of the earnings release or the occurrence of the material news or material event. In addition, if the placement agent agrees to
release any party from the restrictions set forth in the lock-up agreement with such party prior to the expiration of the restricted period, all other parties subject
to the lock-up agreement shall be entitled to a proportionate release of their shares of common stock from the lock-up agreement restrictions.
Our common stock is traded on Nasdaq under the symbol “ORMP.”
The placement agent may distribute this prospectus supplement and the accompanying prospectus electronically.
rt chart bitte
ich das des net
ich das des net
Das kann nicht sein: Es wurde eine Haltefrist von 90 Tagen vereinbart lt Oramed.
oje
wenn ich das richtig deute, dann hat ein fond seine 790.000 stück verkauft.
http://ir.oramed.com/phoenix.zhtml?c=180902&p=IROL-sec
im link seht ihr, dass am 31.12 der investor noch alle stücke hatte und jetzt steht da null
vielleicht täusche ich mich, schaut euch das mal an und gebt mir ein feedback!!!
wenn ich das richtig deute, dann hat ein fond seine 790.000 stück verkauft.
http://ir.oramed.com/phoenix.zhtml?c=180902&p=IROL-sec
im link seht ihr, dass am 31.12 der investor noch alle stücke hatte und jetzt steht da null
vielleicht täusche ich mich, schaut euch das mal an und gebt mir ein feedback!!!
Antwort auf Beitrag Nr.: 46.218.669 von Warnschild am 13.01.14 16:13:25So entstehen Gerüchte. Ein gewisser User (Nichts)Nutz möchte gern bashen.
wird es heute noch mal grün?
wieso schlechte news
kann wer rt chart reinstellen
besten dank
kann wer rt chart reinstellen
besten dank
Antwort auf Beitrag Nr.: 46.218.531 von D 55 am 13.01.14 15:57:40günstig wird es kommen
was gibts denn für schlechte news ?
Ich sehe auch nix. Aber günstig nachkaufen konnte man gerade
Oramed Pharmaceuticals